Immunohistochemical analysis of Gal1 expression in primary EBV+ PTLDs and DLBCLs
Tumors were evaluated by immunohistochemistry with the αGal1 mAb 8F4F8G7 at 1:40 000 (125 ng/mL).
Sign In or Create an Account